Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy

Stem cell-based therapy has drawn attention for enhancing the osseointegration efficiency after joint replacement in the rheumatoid arthritis (RA). However, therapeutic efficacy of this approach is threatened by the accumulated reactive oxygen species (ROS) and poor oxygen supply. Herein, we develop...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhao, Yue, Song, Shanliang, Wang, Dongdong, Liu, He, Zhang, Junmin, Li, Zuhao, Wang, Jincheng, Ren, Xiangzhong, Zhao, Yanli
Other Authors: School of Chemistry, Chemical Engineering and Biotechnology
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/168650
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-168650
record_format dspace
spelling sg-ntu-dr.10356-1686502023-06-16T15:31:40Z Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy Zhao, Yue Song, Shanliang Wang, Dongdong Liu, He Zhang, Junmin Li, Zuhao Wang, Jincheng Ren, Xiangzhong Zhao, Yanli School of Chemistry, Chemical Engineering and Biotechnology Science::Chemistry Catalase Dissolved Oxygen Stem cell-based therapy has drawn attention for enhancing the osseointegration efficiency after joint replacement in the rheumatoid arthritis (RA). However, therapeutic efficacy of this approach is threatened by the accumulated reactive oxygen species (ROS) and poor oxygen supply. Herein, we develop a nanozyme-reinforced hydrogel for reshaping the hostile RA microenvironment and improving prosthetic interface osseointegration. The engineered hydrogel not only scavenges endogenously over-expressed ROS, but also synergistically produces dissolved oxygen. Such performance enables the hydrogel to be utilized as an injectable delivery vehicle of bone marrow-derived mesenchymal stem cells (BMSCs) to protect implanted cells from ROS and hypoxia-mediated death and osteogenic limitation. This nanozyme-reinforced hydrogel encapsulated with BMSCs can alleviate the symptoms of RA, including suppression of local inflammatory cytokines and improvement of osseointegration. This work provides a strategy for solving the long-lasting challenge of stem cell transplantation and revolutionizes conventional intervention methods for improving prosthetic interface osseointegration in RA. Agency for Science, Technology and Research (A*STAR) National Research Foundation (NRF) Published version This work was financially supported by the National Natural Science Foundation of China (22105131 Yue Zhao and 82001971 He Liu), the National Key Technologies Research and Development (R&D) Program of China (2018YFB1105100 Jincheng Wang), the Guangdong Basic and Applied Basic Research Foundation (2022A1515011677 Xiangzhong Ren), and the International Postdoctoral Exchange Fellowship Program (PC2021046 Yue Zhao). This work is also supported by the Singapore Agency for Science, Technology and Research (A*STAR) AME IRG grant (A20E5c0081 Yanli Zhao) and the Singapore National Research Foundation Investigatorship (NRF-NRFI2018-03 Yanli Zhao). 2023-06-13T05:32:25Z 2023-06-13T05:32:25Z 2022 Journal Article Zhao, Y., Song, S., Wang, D., Liu, H., Zhang, J., Li, Z., Wang, J., Ren, X. & Zhao, Y. (2022). Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy. Nature Communications, 13(1), 6758-. https://dx.doi.org/10.1038/s41467-022-34481-5 2041-1723 https://hdl.handle.net/10356/168650 10.1038/s41467-022-34481-5 36351899 2-s2.0-85141505900 1 13 6758 en A20E5c0081 NRF-NRFI2018-03 Nature Communications © 2022 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Chemistry
Catalase
Dissolved Oxygen
spellingShingle Science::Chemistry
Catalase
Dissolved Oxygen
Zhao, Yue
Song, Shanliang
Wang, Dongdong
Liu, He
Zhang, Junmin
Li, Zuhao
Wang, Jincheng
Ren, Xiangzhong
Zhao, Yanli
Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy
description Stem cell-based therapy has drawn attention for enhancing the osseointegration efficiency after joint replacement in the rheumatoid arthritis (RA). However, therapeutic efficacy of this approach is threatened by the accumulated reactive oxygen species (ROS) and poor oxygen supply. Herein, we develop a nanozyme-reinforced hydrogel for reshaping the hostile RA microenvironment and improving prosthetic interface osseointegration. The engineered hydrogel not only scavenges endogenously over-expressed ROS, but also synergistically produces dissolved oxygen. Such performance enables the hydrogel to be utilized as an injectable delivery vehicle of bone marrow-derived mesenchymal stem cells (BMSCs) to protect implanted cells from ROS and hypoxia-mediated death and osteogenic limitation. This nanozyme-reinforced hydrogel encapsulated with BMSCs can alleviate the symptoms of RA, including suppression of local inflammatory cytokines and improvement of osseointegration. This work provides a strategy for solving the long-lasting challenge of stem cell transplantation and revolutionizes conventional intervention methods for improving prosthetic interface osseointegration in RA.
author2 School of Chemistry, Chemical Engineering and Biotechnology
author_facet School of Chemistry, Chemical Engineering and Biotechnology
Zhao, Yue
Song, Shanliang
Wang, Dongdong
Liu, He
Zhang, Junmin
Li, Zuhao
Wang, Jincheng
Ren, Xiangzhong
Zhao, Yanli
format Article
author Zhao, Yue
Song, Shanliang
Wang, Dongdong
Liu, He
Zhang, Junmin
Li, Zuhao
Wang, Jincheng
Ren, Xiangzhong
Zhao, Yanli
author_sort Zhao, Yue
title Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy
title_short Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy
title_full Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy
title_fullStr Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy
title_full_unstemmed Nanozyme-reinforced hydrogel as a H₂O₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy
title_sort nanozyme-reinforced hydrogel as a h₂o₂-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy
publishDate 2023
url https://hdl.handle.net/10356/168650
_version_ 1772825808299098112